IRIS Accounts Production v25.1.3.33 SC162036 Board of Directors 1.4.24 31.3.25 31.3.25 Medium entities provision of residential, nursing and enhanced residential care. true true false true true false false true true false These accounts have been prepared in accordance with the provisions applicable to companies subject to the medium-sized companies regime. Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWhSC1620362024-03-31SC1620362025-03-31SC1620362024-04-012025-03-31SC1620362023-03-31SC1620362023-04-012024-03-31SC1620362024-03-31SC162036ns15:Scotland2024-04-012025-03-31SC162036ns14:PoundSterling2024-04-012025-03-31SC162036ns10:Director12024-04-012025-03-31SC162036ns10:PrivateLimitedCompanyLtd2024-04-012025-03-31SC162036ns10:MediumEntities2024-04-012025-03-31SC162036ns10:Audited2024-04-012025-03-31SC162036ns10:Medium-sizedCompaniesRegimeForDirectorsReport2024-04-012025-03-31SC162036ns10:Medium-sizedCompaniesRegimeForAccounts2024-04-012025-03-31SC162036ns10:FullAccounts2024-04-012025-03-31SC162036ns10:OrdinaryShareClass12024-04-012025-03-31SC162036ns10:Director22024-04-012025-03-31SC162036ns10:RegisteredOffice2024-04-012025-03-31SC16203612024-04-012025-03-31SC16203612023-04-012024-03-31SC16203622024-04-012025-03-31SC16203622023-04-012024-03-31SC162036ns5:CurrentFinancialInstruments2025-03-31SC162036ns5:CurrentFinancialInstruments2024-03-31SC162036ns5:Non-currentFinancialInstruments2025-03-31SC162036ns5:Non-currentFinancialInstruments2024-03-31SC162036ns5:ShareCapital2025-03-31SC162036ns5:ShareCapital2024-03-31SC162036ns5:RevaluationReserve2025-03-31SC162036ns5:RevaluationReserve2024-03-31SC162036ns5:RetainedEarningsAccumulatedLosses2025-03-31SC162036ns5:RetainedEarningsAccumulatedLosses2024-03-31SC162036ns5:ShareCapital2023-03-31SC162036ns5:RetainedEarningsAccumulatedLosses2023-03-31SC162036ns5:RevaluationReserve2023-03-31SC162036ns5:RetainedEarningsAccumulatedLosses2023-04-012024-03-31SC162036ns5:RevaluationReserve2023-04-012024-03-31SC162036ns5:RetainedEarningsAccumulatedLosses2024-04-012025-03-31SC162036ns5:RevaluationReserve2024-04-012025-03-31SC162036ns5:LandBuildingsns5:OwnedOrFreeholdAssets2024-04-012025-03-31SC162036ns5:PlantMachinery2024-04-012025-03-31SC162036ns5:FurnitureFittings2024-04-012025-03-31SC162036ns5:MotorVehicles2024-04-012025-03-31SC162036ns5:OwnedAssets2024-04-012025-03-31SC162036ns5:OwnedAssets2023-04-012024-03-31SC162036ns10:OrdinaryShareClass12023-04-012024-03-31SC162036ns5:LandBuildings2024-03-31SC162036ns5:PlantMachinery2024-03-31SC162036ns5:FurnitureFittings2024-03-31SC162036ns5:MotorVehicles2024-03-31SC162036ns5:LandBuildings2024-04-012025-03-31SC162036ns5:LandBuildings2025-03-31SC162036ns5:PlantMachinery2025-03-31SC162036ns5:FurnitureFittings2025-03-31SC162036ns5:MotorVehicles2025-03-31SC162036ns5:LandBuildings2024-03-31SC162036ns5:PlantMachinery2024-03-31SC162036ns5:FurnitureFittings2024-03-31SC162036ns5:MotorVehicles2024-03-31SC162036ns5:CostValuation2025-03-31SC162036ns5:Subsidiary12024-04-012025-03-31SC1620361ns5:Subsidiary12024-04-012025-03-31SC162036ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-31SC162036ns5:WithinOneYearns5:CurrentFinancialInstruments2024-03-31SC162036ns5:DeferredTaxation2024-03-31SC162036ns5:DeferredTaxation2024-04-012025-03-31SC162036ns5:DeferredTaxation2025-03-31SC162036ns10:OrdinaryShareClass12025-03-31SC162036ns5:RetainedEarningsAccumulatedLosses2024-03-31SC162036ns5:RevaluationReserve2024-03-31
REGISTERED NUMBER: SC162036 (Scotland)












Strategic Report,

Report of the Directors and

Financial Statements

for the Year Ended 31 March 2025

for

Oakminster Healthcare Limited

Oakminster Healthcare Limited (Registered number: SC162036)






Contents of the Financial Statements
for the Year Ended 31 March 2025




Page

Company Information 1

Strategic Report 2

Report of the Directors 3

Report of the Independent Auditors 5

Income Statement 8

Other Comprehensive Income 9

Balance Sheet 10

Statement of Changes in Equity 11

Notes to the Financial Statements 12


Oakminster Healthcare Limited

Company Information
for the Year Ended 31 March 2025







DIRECTORS: Ms L M Di Giacomo
Mrs S Poddar



REGISTERED OFFICE: Head Office
40 Lambhill Street
Kinning Park
Glasgow
G41 1AU



REGISTERED NUMBER: SC162036 (Scotland)



AUDITORS: O'Haras Accountants Limited (Statutory Auditor)
Radleigh House
1 Golf Road
Clarkston
Glasgow
G76 7HU



SOLICITORS: Morton Fraser MacRoberts Lawyers
Capella Building
60 York St
Glasgow
G2 8JX

Oakminster Healthcare Limited (Registered number: SC162036)

Strategic Report
for the Year Ended 31 March 2025

The directors present their strategic report for the year ended 31 March 2025.

REVIEW OF BUSINESS
The company aims to ensure that all residents receive the highest possible care through quality staffing and aesthetically pleasing accommodation.

Key performance indicators 2025 2024
Gross profit % 38.33% 34.06%

Turnover has increased by 12.59%. This is primarily due to increased occupancy rates.

PRINCIPAL RISKS AND UNCERTAINTIES
Competitive Risks
The group is reliant on placements from local authorities.

There continues to be a national shortage of nurses within the UK which may increase employment costs. Also, the Scottish Executive is coming under increasing pressure to provide direct care to the elderly in their own homes which may have an impact on our occupancy.

Legislative Risks
There is increasing pressure to ensure all staff are trained to the highest standard. This is challenging due to the diverse needs of residents being admitted. This standard is subject to continuous revision in relation to current staff employed and may have a direct impact on funding.

Financial Risks
Credit risk and cash flow risk are low with local authorities representing by far the largest proportion of the group's customer base and payment of outstanding debts is generally made every four weeks. The local authority also underwrites any debt arising from the contribution received directly from residents.

FUTURE DEVELOPMENTS
The immediate priorities for the group are to improve the level of care and facilities offered to its residents, and to manage the overheads of the business to improve profitability.

ON BEHALF OF THE BOARD:





Mrs S Poddar - Director


22 December 2025

Oakminster Healthcare Limited (Registered number: SC162036)

Report of the Directors
for the Year Ended 31 March 2025

The directors present their report with the financial statements of the company for the year ended 31 March 2025.

DIVIDENDS
An interim dividend of £4,375 per share was paid each month in the financial year to 31 March 2025. The directors recommend that no final dividend be paid on the shares.

The total distribution of dividends for the year ended 31 March 2025 will be £105,000.

DIRECTORS
The directors shown below have held office during the whole of the period from 1 April 2024 to the date of this report.

Ms L M Di Giacomo
Mrs S Poddar

DISABLED PERSONS
Applications for employment by disabled persons are always fully considered, bearing in mind the aptitudes of the applicant concerned. In the event of members of staff becoming disabled, every effort is made to ensure that their employment within the company continues and that the appropriate training is arranged. It is the policy of the company that the training, career development and promotion of disabled persons should, as far as possible, be identical to that of other employees.

ENGAGEMENT WITH EMPLOYEES
The company's policy is to consult and discuss with employees, through unions, staff councils and at meetings, matters likely to affect employees' interests.

Information about matters of concern to employees is given through information bulletins and reports which seek to achieve a common awareness on the part of all employees of the financial and economic factors affecting the company's performance.

STATEMENT OF DIRECTORS' RESPONSIBILITIES
The directors are responsible for preparing the Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

-select suitable accounting policies and then apply them consistently;
-make judgements and accounting estimates that are reasonable and prudent;
-prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.


STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditors are unaware, and each director has taken all the steps that she ought to have taken as a director in order to make herself aware of any relevant audit information and to establish that the company's auditors are aware of that information.

Oakminster Healthcare Limited (Registered number: SC162036)

Report of the Directors
for the Year Ended 31 March 2025


AUDITORS
The auditors, O'Haras Accountants Limited (Statutory Auditor), will be proposed for re-appointment at the forthcoming Annual General Meeting.

ON BEHALF OF THE BOARD:





Mrs S Poddar - Director


22 December 2025

Report of the Independent Auditors to the Members of
Oakminster Healthcare Limited

Opinion
We have audited the financial statements of Oakminster Healthcare Limited (the 'company') for the year ended 31 March 2025 which comprise the Income Statement, Other Comprehensive Income, Balance Sheet, Statement of Changes in Equity and Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:
-give a true and fair view of the state of the company's affairs as at 31 March 2025 and of its profit for the year then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information
The directors are responsible for the other information. The other information comprises the information in the Strategic Report and the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements.

Report of the Independent Auditors to the Members of
Oakminster Healthcare Limited


Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report or the Report of the Directors.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:
- adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
- the financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of directors' remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit.

Responsibilities of directors
As explained more fully in the Statement of Directors' Responsibilities set out on page three, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

- We gained an understanding of the legal and regulatory framework applicable to the company and the industry in which it operates, primarily in residential and nursing healthcare. We made enquiries of management as to whether there were any known or suspected instances of non-compliance with laws and regulations or fraud, and reviewed available board minutes for any indication of such matters.
- We gained an understanding of management's internal controls designed to prevent and detect irregularities in their day-to-day operations.
- We considered laws and regulations which could give rise to a material misstatement in the financial statements, including, but not limited to, the Companies Act 2006 and UK tax legislation. We assessed the extent of compliance with these laws and regulations as part of our procedures on the related financial statement components. Our tests included agreeing the financial statement disclosures to underlying supporting documentation, enquiries with management and enquiries of relevant third parties.
- We considered how fraud might occur in this company and designed our tests accordingly.
- As in all audits, we also addressed the risk of management override of internal controls, including reviewing journals and evaluating whether there was evidence of bias by the directors that represented a risk of material misstatement due to fraud.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

Report of the Independent Auditors to the Members of
Oakminster Healthcare Limited


Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.




John O'Hara CA (Senior Statutory Auditor)
for and on behalf of O'Haras Accountants Limited (Statutory Auditor)
Radleigh House
1 Golf Road
Clarkston
Glasgow
G76 7HU

22 December 2025

Oakminster Healthcare Limited (Registered number: SC162036)

Income Statement
for the Year Ended 31 March 2025

2025 2024
Notes £    £   

TURNOVER 13,359,949 11,865,534

Cost of sales 8,239,374 7,823,799
GROSS PROFIT 5,120,575 4,041,735

Administrative expenses 3,817,225 3,601,342
1,303,350 440,393

Other operating income 111,250 1,232,204
OPERATING PROFIT 4 1,414,600 1,672,597

Interest receivable and similar income 27,095 25,875
1,441,695 1,698,472

Interest payable and similar expenses 5 1,047,555 1,094,250
PROFIT BEFORE TAXATION 394,140 604,222

Tax on profit 6 268,654 118,344
PROFIT FOR THE FINANCIAL YEAR 125,486 485,878

Oakminster Healthcare Limited (Registered number: SC162036)

Other Comprehensive Income
for the Year Ended 31 March 2025

2025 2024
Notes £    £   

PROFIT FOR THE YEAR 125,486 485,878


OTHER COMPREHENSIVE INCOME
Revaluations - 1,469,119
Deferred tax on revaluation reserve - (367,279 )
Income tax relating to components of other
comprehensive income

-

-
OTHER COMPREHENSIVE INCOME
FOR THE YEAR, NET OF INCOME TAX

-

1,101,840
TOTAL COMPREHENSIVE INCOME
FOR THE YEAR

125,486

1,587,718

Oakminster Healthcare Limited (Registered number: SC162036)

Balance Sheet
31 March 2025

2025 2024
Notes £    £    £   
FIXED ASSETS
Tangible assets 8 14,510,111 15,090,375
Investments 9 2,006,811 2,006,811
16,516,922 17,097,186

CURRENT ASSETS
Debtors 10 999,916 1,044,783
Cash at bank 2,955,400 1,720,963
3,955,316 2,765,746
CREDITORS
Amounts falling due within one year 11 5,414,342 4,401,395
NET CURRENT LIABILITIES (1,459,026 ) (1,635,649 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

15,057,896

15,461,537

CREDITORS
Amounts falling due after more than one year 12 (12,942,691 ) (13,386,691 )

PROVISIONS FOR LIABILITIES 14 (685,392 ) (665,519 )
NET ASSETS 1,429,813 1,409,327

CAPITAL AND RESERVES
Called up share capital 15 2 2
Revaluation reserve 16 1,069,102 1,101,840
Retained earnings 16 360,709 307,485
SHAREHOLDERS' FUNDS 1,429,813 1,409,327

The financial statements were approved by the Board of Directors and authorised for issue on 22 December 2025 and were signed on its behalf by:





Mrs S Poddar - Director


Oakminster Healthcare Limited (Registered number: SC162036)

Statement of Changes in Equity
for the Year Ended 31 March 2025

Called up
share Retained Revaluation Total
capital earnings reserve equity
£    £    £    £   
Balance at 1 April 2023 2 (178,393 ) - (178,391 )

Changes in equity
Total comprehensive income - 485,878 1,101,840 1,587,718
Balance at 31 March 2024 2 307,485 1,101,840 1,409,327

Changes in equity
Dividends - (105,000 ) - (105,000 )
Total comprehensive income - 158,224 (32,738 ) 125,486
Balance at 31 March 2025 2 360,709 1,069,102 1,429,813

Oakminster Healthcare Limited (Registered number: SC162036)

Notes to the Financial Statements
for the Year Ended 31 March 2025

1. ACCOUNTING POLICIES

Basis of preparing the financial statements
Going concern
The directors have considered the financial position of the company, including its capital and liquidity resources, and have prepared forecasts that take into account reasonably foreseeable changes in trading performance. On the basis of these assessments and the continued availability of banking facilities, the directors are satisfied that the company has adequate resources to continue in operational existence for the foreseeable future. Accordingly, the financial statements have been prepared on a going concern basis.

The company has taken advantage of the exemption under section 400 of the Companies Act 2006 not to prepare consolidated accounts. The financial statements present information about the company as an individual entity and not about its group.

Oakminster Healthcare Limited is a wholly owned subsidiary of Oakminster Group Limited and the results of Oakminster Healthcare Limited are included in the consolidated financial statements of Oakminster Group Limited which are available from 40 Lambhill Street, Kinning Park, Glasgow, G41 1AU.

Revenue
Turnover represents amounts receivable in respect of the accounting period from the provision of nursing and enhanced residential care. Turnover is recognised in the accounting period in which the provision of such nursing and enhanced residential care takes place.

The total turnover of the company for the year has been derived from its principal activity wholly undertaken in the UK.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.
Freehold property - 2% on cost
Plant and machinery - 20% on reducing balance
Fixtures and fittings - 20% on reducing balance
Motor vehicles - at variable rates on reducing balance

Investments in associates
Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.


Oakminster Healthcare Limited (Registered number: SC162036)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

1. ACCOUNTING POLICIES - continued
Taxation
The tax expense represents the sum of the current tax expense and deferred tax expense. Current tax assets are recognised when tax paid exceeds the tax payable.

Current and deferred tax is charged or credited to profit and loss, except when it relates to items charged or credited to other comprehensive income or equity, when the tax follows the transaction or event it relates to and is also charged or credited to other comprehensive income, or equity.

Current tax assets and current tax liabilities and deferred tax assets and deferred tax liabilities are offset, if and only if, there is a legally enforceable right to set off the amounts and the entity intends either to settle on the net basis or to realise the asset and settle the liability simultaneously.

Current tax is based on taxable profit for the year. Current tax assets and liabilities are measured using tax rates that have been enacted or substantively enacted by the reporting date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date where transactions or events that result in an obligation to pay more tax in the future or a right to pay less tax in the future have occurred at the balance sheet date. Timing differences are differences between the company's taxable profits and its results as stated in the financial statements that arise from the inclusion of gains and losses in tax assessments in periods difference from those in which they are recognised in the financial statements.

Deferred tax is measured at the average tax rates that are expected to apply in the periods in which timing differences are expected to reverse, based on tax rates and laws that have been enacted or substantively enacted by the balance sheet date. Deferred tax is measured on a non-discounted basis.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Trade, other and inter-company debtors
Trade, other and inter-company debtors are recognised initially at the transaction price, or when the arrangement constitutes a financing transaction, at the present value of future payments discounted at a market rate of interest for a similar debt instrument. Trade, other and inter-company debtors are subsequently measured at amortised cost using the effective interest rate method, less any impairment losses.

A provision for impairment of trade, other and inter-company debtors is established when there is objective evidence that the amounts due will not be collected according to the original terms of the contract. Impairment losses are recognised in profit or loss for the excess of the carrying value of the trade or other debtor over the present value of future cash flows discounted using the original effective interest rates. Subsequent reversals of an impairment loss that objectively relate to an event occurring after the impairment loss was recognised, are recognised immediately in profit or loss.

Trade, other and inter-company creditors
Trade, other and inter-company creditors payable within one year that do not constitute a financing transaction are initially measured at the transaction price and subsequently measured at amortised cost, being the transaction price less any amounts settled.

Where the instrument with a trade, other or inter-company creditor constitutes a financing transaction, the creditor is initially and subsequently measured at the present value of future payments discounted at a market rate of interest for a similar instrument.

Oakminster Healthcare Limited (Registered number: SC162036)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

1. ACCOUNTING POLICIES - continued

Impairment of fixed assets
At each balance sheet date, the company reviews the carrying amount of its tangible fixed assets to determine whether there is any indication that any items have suffered an impairment loss. If any such indication exists, the recoverable amount of an asset is estimated in order to determine the extent of the impairment loss, if any. Where it is not possible to estimate the recoverable amount of the asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Cash and cash equivalents
Cash and cash equivalents includes cash in hand, deposits held at call with banks, other short-term highly liquid investments with original maturities of three months or less and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

Grants
Grants are accounted for under the accruals model as permitted by FRS 102. Grants relating to expenditure of tangible fixed assets are credited to the profit and loss account at the same rate as the depreciation on the asset to which the grant relates. The deferred element of grants is included in creditors as deferred income. Grants of a revenue nature are recognised in other income within the profit and loss account in the same period as the related expenditure.

2. EMPLOYEES AND DIRECTORS
2025 2024
£    £   
Wages and salaries 7,210,639 6,814,569
Social security costs 616,451 578,182
Other pension costs 158,503 152,990
7,985,593 7,545,741

The average number of employees during the year was as follows:
2025 2024

Nursing staff 308 278
Admin staff 16 23
324 301

3. DIRECTORS' EMOLUMENTS
2025 2024
£    £   
Directors' remuneration 159,000 264,000

The number of directors for whom retirement benefits are accruing under defined contribution schemes amounted to 2 (2024 - 2).

Oakminster Healthcare Limited (Registered number: SC162036)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

4. OPERATING PROFIT

The operating profit is stated after charging:

2025 2024
£    £   
Depreciation - owned assets 621,814 582,973
Auditors' remuneration 23,131 23,089
Auditors' remuneration for non audit work 1,000 1,000

5. INTEREST PAYABLE AND SIMILAR EXPENSES
2025 2024
£    £   
Bank loan interest 1,047,555 1,094,250

6. TAXATION

Analysis of the tax charge
The tax charge on the profit for the year was as follows:
2025 2024
£    £   
Current tax:
UK corporation tax 248,781 -

Deferred tax 19,873 118,344
Tax on profit 268,654 118,344

Reconciliation of total tax charge included in profit and loss
The tax assessed for the year is higher than the standard rate of corporation tax in the UK. The difference is explained below:

2025 2024
£    £   
Profit before tax 394,140 604,222
Profit multiplied by the standard rate of corporation tax in the UK of 25%
(2024 - 25%)

98,535

151,056

Effects of:
Expenses not deductible for tax purposes 14,548 120
Depreciation in excess of capital allowances 135,698 96,580
Adjustments to tax charge in respect of previous periods - 71,740

Fixed asset differences - (280,616 )
Remeasurement of deferred tax for changes in tax rates - 79,464
Deferred tax movement 19,873 -
Total tax charge 268,654 118,344

Oakminster Healthcare Limited (Registered number: SC162036)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

6. TAXATION - continued

Tax effects relating to effects of other comprehensive income

There were no tax effects for the year ended 31 March 2025.

2024
Gross Tax Net
£    £    £   
Revaluations 1,469,119 - 1,469,119
Deferred tax on revaluation reserve (367,279 ) - (367,279 )
1,101,840 - 1,101,840

7. DIVIDENDS
2025 2024
£    £   
Ordinary shares of £1 each
Interim 105,000 -

8. TANGIBLE FIXED ASSETS
Fixtures
Freehold Plant and and Motor
property machinery fittings vehicles Totals
£    £    £    £    £   
COST OR VALUATION
At 1 April 2024 24,350,621 1,708,046 1,409,738 25,094 27,493,499
Additions - 27,673 13,877 - 41,550
Reclassification/transfer (1,122,463 ) - - - (1,122,463 )
At 31 March 2025 23,228,158 1,735,719 1,423,615 25,094 26,412,586
DEPRECIATION
At 1 April 2024 9,905,560 1,367,057 1,118,788 11,719 12,403,124
Charge for year 487,012 71,063 59,920 3,819 621,814
Reclassification/transfer (1,122,463 ) - - - (1,122,463 )
At 31 March 2025 9,270,109 1,438,120 1,178,708 15,538 11,902,475
NET BOOK VALUE
At 31 March 2025 13,958,049 297,599 244,907 9,556 14,510,111
At 31 March 2024 14,445,061 340,989 290,950 13,375 15,090,375

Oakminster Healthcare Limited (Registered number: SC162036)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

8. TANGIBLE FIXED ASSETS - continued

Cost or valuation at 31 March 2025 is represented by:

Fixtures
Freehold Plant and and Motor
property machinery fittings vehicles Totals
£    £    £    £    £   
Valuation in 2024 1,469,119 - - - 1,469,119
Valuation in 2025 (1,122,463 ) - - - (1,122,463 )
Cost 22,881,502 1,735,719 1,423,615 25,094 26,065,930
23,228,158 1,735,719 1,423,615 25,094 26,412,586

Freehold land and buildings were valued on an open market basis on 15 June 2023 by Christie & Co .

9. FIXED ASSET INVESTMENTS
Investments
in
subsidiaries
£   
COST
At 1 April 2024
and 31 March 2025 2,006,811
NET BOOK VALUE
At 31 March 2025 2,006,811
At 31 March 2024 2,006,811

The company's investments at the Balance Sheet date in the share capital of companies include the following:

Oakbridge Care Limited
Registered office: 40 Lambhill Street, Kinning Park, Glasgow, G41 1AU
Nature of business: Care home services
%
Class of shares: holding
Ordinary 100.00

10. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade debtors 905,932 943,585
Other debtors - 13,664
Prepayments and accrued income 93,984 87,534
999,916 1,044,783

Oakminster Healthcare Limited (Registered number: SC162036)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

11. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Bank loans and overdrafts (see note 13) 444,000 444,000
Trade creditors 551,095 569,657
Amounts owed to group undertakings 920,648 357,158
Tax 248,781 -
Social security and other taxes 146,569 139,141
Other creditors 667,624 612,812
Directors' current accounts 1,541,313 1,541,313
Accruals and deferred income 894,312 737,314
5,414,342 4,401,395

12. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2025 2024
£    £   
Bank loans (see note 13) 12,942,691 13,386,691

13. LOANS

The bank loans and overdrafts are secured by a fixed charge and floating charge over the assets of the group and company.

There is a floating charge,which covers all the property of the company, in favour of the director Sunita Poddar.

14. PROVISIONS FOR LIABILITIES
2025 2024
£    £   
Deferred tax 685,392 665,519

Deferred
tax
£   
Balance at 1 April 2024 665,519
Provided during year 19,873
Balance at 31 March 2025 685,392

15. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2025 2024
value: £    £   
2 Ordinary £1 2 2

Oakminster Healthcare Limited (Registered number: SC162036)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2025

16. RESERVES
Retained Revaluation
earnings reserve Totals
£    £    £   

At 1 April 2024 307,485 1,101,840 1,409,325
Profit for the year 125,486 125,486
Dividends (105,000 ) (105,000 )
Transfer between reserves 32,738 (32,738 ) -
At 31 March 2025 360,709 1,069,102 1,429,811

17. ULTIMATE PARENT COMPANY

Oakminster Group Limited is regarded by the directors as being the company's ultimate parent company.

The registered office of Oakminster Group Limited is 40 Lambhill Street, Kinning Park, Glasgow, G41 1AU.

Oakminster Group Limited is the smallest group for which consolidated accounts are prepared. These can be obtained from Companies House, 4th Floor, Edinburgh Quay 2, 139 Fountainbridge, Edinburgh, EH3 9FF

18. RELATED PARTY DISCLOSURES

The company has taken advantage of the exemption in section 33.1A of FRS 102 whereby transactions with the parent company and wholly-owned members of the group have not been disclosed.